Lupin Gets USFDA Nod For Biosimilar Drug
Published on: Dec. 1, 2025, 3:45 p.m. | Source: NDTV Profit
Drug maker Lupin on Monday said it has received approval from the US health regulator for a biosimilar indicated for the treatment of neutropenia in cancer patients.
